INTRODUCTION
Salmonella enterica is an important zoonotic pathogen with the ability to infect a wide range of animal hosts. Infections can range in severity from subclinical infection, through mild diarrhoea, to severe systemic disease. In foodproducing animals such as pigs, calves and chickens S. enterica is a major cause of disease. Infections in pigs are predominantly associated with serovars Choleraesuis and Typhimurium. S. enterica serovar Choleraesuis (S. Choleraesuis) causes a systemic, sometimes fatal, infection while S. Typhimurium causes a self-limiting enterocolitis but is rarely associated with mortality. A characteristic of serovar Typhimurium infection of pigs, however, is its ability to produce persistent and asymptomatic infections. Pigs with persistent infections can harbour and shed S. Typhimurium in their faeces for several months postexposure (Berends et al., 1996) . These carriers and shedders can contaminate the food chain and environment via meat and faeces and represent a significant reservoir of human Salmonella infection (Hurd et al., 2002) . In a year-long randomized UK national abattoir survey, S. Typhimurium was detected in the caeca of 11.1 % of pigs presented for slaughter and on 2.1 % of carcass swabs (Davies et al., 2004) . Although serovar Typhimurium is the principal serovar isolated from UK pig herds our understanding of the pathogenesis of S. Typhimurium infections in swine is limited as relatively few studies have been carried out using pigs as an experimental model. system (T3SS-1) plays a pivotal role in intestinal, but not tonsillar, colonization in pigs (Boyen et al., 2006b) , as well as in invasion of porcine pulmonary alveolar macrophages (Boyen et al., 2006a) . Type I fimbriae have also been implicated in intestinal colonization of swine by serovar Typhimurium (Althouse et al., 2003) . Most in vivo pig studies have focused on serovar Choleraesuis. Experimental studies using this serovar have indicated a role for the SPI-1 transcriptional regulator hilA in enteric infection in pigs and, more recently, screening of random S. Choleraesuis mutants identified a number of SPI-1 and SPI-2 genes essential for systemic infection of pigs (Ku et al., 2005; Lichtensteiger & Vimr, 2003) .
Working towards the aims of enhancing the health and welfare of farmed pigs and improving food safety, we have used signature-tagged mutagenesis (STM; Hensel et al., 1995) as a rapid high-throughput screen for S. Typhimurium factors that may be suitable for inclusion in vaccines. STM permits the simultaneous analysis of up to 95 uniquely tagged transposon insertion mutants for defects in virulence and has been used as a prelude to the testing of vaccines against a variety of bacterial pathogens (Collins et al., 2005; Flashner et al., 2004; Ku et al., 2005) . This method has revealed that Salmonella uses both conserved and host-specific colonization factors in calves, chickens and mice (Bispham et al., 2001; Hensel et al., 1995; Morgan et al., 2004; Shah et al., 2005; Tsolis et al., 1999) . Increasing awareness that Salmonella requires different genes in different hosts reinforces the need to extend these studies to a porcine model of infection.
Screening of the same serovar Typhimurium mutant library as recently characterized in calves and chickens (Morgan et al., 2004) identified 95 genes required for intestinal colonization of pigs. The data from this comprehensive survey indicate that secreted and surfaceanchored molecules, including fimbriae and type III secreted proteins, play pivotal roles in the carriage of S. Typhimurium in pigs. Vaccines based on extracellular factors and type III secreted proteins have shown protection against other bacterial pathogens, including Yersinia pestis in mice and enterohaemorrhagic Escherichia coli in cattle (Leary et al., 1995; Potter et al., 2004) . We therefore exploited insights from STM to evaluate the efficacy of a S. Typhimurium secreted protein vaccine and probed the role of T3SS-1-secreted proteins in the protection observed.
METHODS
Bacterial strains and culture conditions. A nalidixic acid resistant mutant of Salmonella Typhimurium ST4/74 (a progenitor of SL1344; ST4/74 Nal R ) and a prgH : : mini-Tn5Km2 mutant of ST4/74 Nal R were used in this study (Morgan et al., 2004) . Both strains exhibited wild-type growth characteristics. Escherichia coli strain TOP10F9 (Invitrogen) was used for subcloning of transposon-containing fragments in plasmid pBluescript KS(+) (Short et al., 1988) . S. Typhimurium and E. coli strains were grown in LB broth with appropriate antibiotics. Antibiotics were used at the following concentrations unless otherwise indicated: ampicillin (Amp; 100 mg ml 21 ), kanamycin (Km; 50 mg ml 21 ), nalidixic acid (Nal; 20 mg ml
21
). Cultures were grown at 37 uC with aeration in a rotary shaker unless otherwise indicated.
Experimental animals. All animal experiments were conducted according to the requirements of the Animals (Scientific Procedures) Act 1986 Act (licence 30/1998 and were approved by the local ethical review committee. Large White6Landrace crossbred pigs were obtained from an established Salmonella-free commercial farm. Pigs were housed in a medium containment unit and fed twice daily on a diet of antibiotic-free weaner pellets with water freely available. All experimental animals were confirmed to be culture-negative for Salmonella by enrichment of rectal swabs overnight in Rappaport and Selenite broth followed by subsequent culture on Brilliant Green agar (Oxoid) for 16 h. Analysis of pre-vaccination serum IgG confirmed negligible levels of sero-reactivity to Salmonella in the animals used for vaccination and challenge studies.
In vivo screening of a ST4/74 Nal R STM mutant library. A library of 1045 signature-tagged mini-Tn5Km2 transposon insertion mutants of ST4/74 Nal R previously described by Morgan et al. (2004) was used for this study. Eleven pools of 95 mutants were grown in LB broth in microtitre trays at 37 uC for 16 h with aeration. Aliquots were removed from each of the 11 pools and used for preparation of 'input pool' genomic DNA by the CTAB (N-cetyl-N,N,N-trimethylammonium bromide) method (Hensel et al., 1995) . For each pool, two 6-week-old pigs were fasted for 12 h prior to infection and orally dosed with~10 10 c.f.u. per input pool. A section of distal ileal mucosa, excluding Peyer's patches, was aseptically excised at post mortem examination 3 days post-infection and triplicate 1 g samples were homogenized in 9 ml 0.9 % saline. Bacteria (in excess of 10 000 colonies) were recovered from homogenized ileal mucosa by plating onto MacConkey agar containing Nal and Km. Bacteria were pooled and used for preparation of 'output pool' genomic DNA. Signature tags from input and output pools were amplified from genomic DNA using primers P2 (59-TACCTACAACCTCAAGCTT-39) and P4 (59-TACCCATTCTAACCAAGC-39). Tags were subsequently labelled with [ 32 P]dCTP by PCR as described previously (Morgan et al., 2004) . [
32 P]dCTP labelled signature-tag probes were hybridized to a corresponding pool of signature-tag PCR products amplified from each of 95 pUTmini-Tn5Km2 plasmids using primers P6pair (59-GATCAGATCTGGCCGCCTAGGC-39) and PXho (59-TTATGAGC-CATATTCAACGGG-39). Dot blots and hybridizations were performed as described previously (Morgan et al., 2004) . Duplicate dot blots were prepared for both input pools and output pools from each of two pigs to reduce artefacts.
For spiked pools, selected attenuated mutants identified in the primary screen, and colonization-proficient mutants with compatible tags, were picked into individual wells of 96-well microtitre plates containing LB broth supplemented with Nal and Km. All spiked pools contained less than 25 % known attenuated mutants. Pools were tested in the STM pig infection model as described above.
Identification of colonization-defective mutants. Attenuated mutants were identified as producing a weaker hybridization signal in the output pool of at least one pig compared to the input pool, from duplicate dot blots, when compared by eye by two independent researchers. The site of the transposon insertion in attenuated mutants was then determined. EcoRI-, PstI-or EagI-restricted genomic DNA was ligated into similarly restricted pBluescript KS(+) and transformed into chemically competent E. coli TOP10F9. Sequencing of DNA flanking the transposon was performed by Lark Technologies using mini-Tn5Km2 specific primers P6 (59-CCTAGGCGGCCAGATCTG-39) or P10 (59-TCCTCTAGAGTCGA-CCTGC-39). The location of transposon insertions was identified by BLAST-N alignment using the GenBank, National Center for Biotechnology Information (NCBI, http://www.ncbi.nlm.nih.gov/) and coliBase (http://colibase.bham.ac.uk) databases. Sequence data are available from the authors on request.
In vivo co-infection study. Mixed infections with mutant and wildtype strains were used to confirm attenuation of a S. Typhimurium safA mutant. Cultures of wild-type ST4/74 Nal R and a ST4/74 Nal R safA : : mini-Tn5Km2 transductant (described below) were adjusted to the same OD 600 and mixed in a 1 : 1 ratio prior to oral inoculation of two 6-week-old pigs. Each pig was challenged with a total dose of 10 10 c.f.u. Post mortem examination was performed 5 days post-infection and bacteria were recovered from homogenized ileal mucosa by plating onto Brilliant Green agar containing Nal or Nal plus Km to enumerate the mutant strain. The number of viable wild-type bacteria was calculated by subtracting the count on Nal plus Km medium from that on the Nal plates. The ratio of mutant to wild-type bacteria recovered from ileal mucosa was compared to the ratio of mutant to wild-type bacteria in the original inoculum and the data were statistically analysed by t-test.
Transduction of safA : : mini-Tn5Km2 between strains of S.
Typhimurium. A safA mutation was introduced into the archived S. Typhimurium ST4/74 Nal R strain by transduction with bacteriophage P22 HT/int. A donor lysate of P22 HT/int was prepared by the addition of phage to an exponential-phase LB culture of the original safA : : mini-Tn5Km2 mutant strain at a m.o.i. of 0.03. Cultures were reincubated for 3 h at 37 uC with shaking. Bacteria were removed by centrifugation at 11 000 g for 10 min and the supernatant filtered through a 0.45 mm filter. The resulting lysate was added to a broth culture of recipient S. Typhimurium ST4/74 Nal R at a m.o.i. of~0.8. After static incubation at 37 uC for 30 min, the mixture was plated onto LB agar containing Nal and Km. Transposon insertion sites were confirmed by PCR and Southern blot analysis as described previously (Morgan et al., 2004) using transposon-specific primer P10 (as above) and gene-specific primer safA_for (59-TGTTATTACCAGCCACG-GATT-39). The transduced mutant was checked for non-agglutination with 5 % acriflavine/HCl to confirm normal expression of lipopolysaccharide.
Preparation of secreted proteins. Secreted proteins were prepared from ST4/74 Nal R and ST4/74 Nal R prgH : : mini-Tn5Km2. Bacteria were grown to OD 600 1.0 in Dulbecco's Modified Eagle's Medium (DMEM), cells pelleted by centrifugation (8000 g, 15 min, 4 uC) and supernatants collected. Supernatants were filtered using 0.45 mm pore size low-protein-binding filters (Millipore) and proteins were precipitated on ice with 10 % (v/v; final concentration) trichloroacetic acid for 1 h. After centrifugation (10 000 g, 20 min, 22 uC) pellets were washed in ice-cold acetone and resuspended in PBS. At least four independent extractions for each vaccine preparation were pooled to minimize differences in protein recovery from sample to sample. After dialysis an aliquot from each vaccine preparation was removed and boiled in SDS buffer for 5 min, followed by separation using 10 % (w/v) SDS-PAGE to assess the yield, size and stability of proteins. Prior to vaccine formulation each protein preparation was analysed by Cambrex Bio Science to ensure that endotoxin levels were within recommended standards of the European Pharmacopeia (Ph.Eur.), which limits the endotoxin content of a porcine vaccine to 1610 6 international endotoxin units (IEU) per dose (wild-type vaccine, 9610 2 IEU per dose; prgH vaccine 2610 3 IEU per dose).
As type III secreted proteins are a major component of wild-type secreted protein preparations, the protein profile of the prgH mutant was compared visually with the wild-type secreted protein profile to normalize the prgH preparation based on the relative concentrations of the FliC (flagellin) protein. Adjustments based on FliC levels were also confirmed to result in comparable levels of the secreted SPI-4-encoded 600 kDa SiiE protein, thus equivalent levels of non-SPI-1 related secreted factors were represented in both vaccine formulations.
Experimental immunization and infection procedures. Vaccines were formulated 1 : 1 with Freund's incomplete adjuvant (SigmaAldrich) prior to immunization. On day 0 three groups of four 5-weekold pigs were immunized intramuscularly (i.m.) with either 100 mg wild-type secreted protein vaccine, an equivalent quantity of prgH mutant vaccine, based on normalization relative to the FliC and SiiE proteins, or mock vaccine (PBS formulated with Freund's incomplete adjuvant) in a 1 ml volume. Due to concerns regarding health status one pig was removed from the prgH vaccine group prior to immunization, reducing the prgH vaccine group size to 3 pigs. At day 22 each pig was given an i.m. booster vaccination of either 200 mg wild-type secreted protein vaccine, an equivalent quantity of prgH mutant vaccine, or mock vaccine in a 1 ml volume. At day 37 all pigs were challenged by oralgastric intubation with 5610 9 c.f.u. ST4/74 Nal R in a 10 ml volume administered with 10 ml antacid [sterile double-distilled water containing 5 % (w/v) Mg(SiO 3 ) 3 , 5 % (w/v) NaHCO 3 , and 5 % (w/v) MgCO 3 ]. Clinical signs of infection, including pyrexia, general demeanour, fluid and food intake, faecal consistency and faecal content, were monitored twice daily for 6 days post-infection. Faecal excretion of ST4/74 Nal R was quantified by plating serial dilutions of faecal samples collected per rectum onto Brilliant Green agar containing Nal. Any pigs reaching predefined humane end points were humanely killed with an overdose of barbiturate. All other pigs were killed 6 days post-infection. Serum was obtained by bleeding from the anterior vena cava prior to primary vaccination (pre-immune), booster vaccination (pre-boost) and challenge (pre-infection). Blood sampling was also performed at post mortem examination.
ELISA. Maxisorp plates (NUNC, Fisher Scientific) were coated with carbonate buffer (Na 2 CO 3 10 mM; NaHCO 3 35 mM; pH 9.6) containing 0.5 mg ml 21 wild-type or an equivalent quantity of prgH mutant vaccine based on normalization relative to the FliC and SiiE for 16 h at 4 uC. After washing three times with PBS-T [PBS plus 0.05 % (v/v) Tween 20] plates were blocked with PBS-T containing 3 % (w/v) BSA for 1 h at room temperature. Plates were washed a further three times with PBS-T and incubated for 1 h at room temperature with PBS-T plus 3 % (w/v) BSA containing diluted pig sera (1 : 100) collected on either day 0 (pre-immune), day 22 (preboost), day 37 (pre-infection) or day 43 (post mortem). Plates were washed as above and incubated with PBS-T plus 3 % (w/v) BSA and 1 : 5000 rabbit anti-swine IgG (whole molecule)-AP (Sigma-Aldrich) for 1 h at room temperature. Plates were washed as above and 50 ml pnitrophenyl phosphate substrate added. Colour development was allowed to occur for 30 min and stopped with the addition of 3 M NaOH. The absorbance of each well was read at 405 nm.
Statistical analysis. Statistical analyses of data were performed using the Statistical Analysis System (SAS Institute). Data were transformed exponentially, geometric means determined, and statistical significance of differences was calculated using parametric tests. An F-test with data taken as repeated measurements was used to determine whether administration of wild-type or prgH mutant vaccine resulted in a significant decrease in shedding of ST4/74 Nal R when compared with mock vaccination. Single comparisons between control and treatment means were made with a paired Student's twotailed t-test when appropriate. P values of 0.05 or less were considered significant. All data are expressed as mean±SEM.
RESULTS AND DISCUSSION
In vivo screening of an S. Typhimurium STM mutant library in pigs A library of ST4/74 Nal R signature-tagged mutants was screened for ability to colonize the intestinal tract in a porcine model of infection. In total 1045 signature-tagged mutants were screened in 11 pools of 95 mutants, with each pool screened in two pigs. Of the 1045 mutants screened, 119 mutants representing 95 genes were defective in colonization on the basis that they gave a weak or absent hybridization signal in the output pool recovered from intestinal mucosa of at least one animal. All mutant phenotypes are reported, since numerous mutants which exhibited varying levels of attenuation in replicate animals were significantly attenuated upon retesting in single infection studies (Morgan et al., 2004) . Of the 119 attenuating mutations, the transposon insertion sites of 79 had previously been determined by Morgan et al. (2004) and were attenuated in calves, chickens or both species. The transposon insertion sites of 36 of the remaining 40 mutants were determined during the course of this study and all of these mutants were attenuated in the pig model only. Despite the use of three alternative restriction enzymes we were unable to subclone the remaining four mutants due to difficulties associated with cloning large DNA fragments, probably a consequence of excessive distance between restriction sites in the genome relative to those in the transposon. In addition to the 119 mutants attenuated in pigs, a further 108 mutants (with defects in a total of 83 different genes) that were attenuated in calves and/or chicks (Morgan et al., 2004) exhibited no defect in intestinal colonization of pigs (Table 1) .
To confirm the attenuated phenotypes demonstrated in the primary screen a selection of transposon mutants representing Salmonella pathogenicity islands (SPIs) and fimbrial loci (prgK, ssaQ, sugR, mgtC, pipC, safA, stbC, stbD) were spiked into fresh pools of 95 among tagged but colonization-proficient mutants and retested in the pig infection model as described. All mutants were consistently attenuated in the second screen (Table 1) .
Of the 119 mutants attenuated in pigs, 54 contained transposon insertions within known SPIs, with a striking 49 insertions located in 32 genes of SPIs-1 and -2. SPI-1 encodes T3SS-1 and a number of secreted translocator proteins and facilitates Salmonella invasion of host epithelial cells by injection of effector proteins into enterocytes that stimulate rearrangements of the subcortical actin cytoskeleton (Galan & Curtiss, 1989; Galan, 1996; Jones & Falkow, 1994) . T3SS-1-secreted effectors also act in concert to influence the induction of enteritis (Drecktrah et al., 2005; Galyov et al., 1997; Zhou & Galan, 2001) . SPI-2 encodes T3SS-2 and expression of T3SS-2 and associated effectors facilitates the persistence of intracellular bacteria within membrane-bound Salmonella-containing vacuoles (Hensel et al., 1995; Hensel, 2000; Shea et al., 1996) .
The isolation of multiple independent attenuating mutations in structural and secreted components of T3SS-1 and T3SS-2 markedly reduces the likelihood that attenuation of SPI-1 or -2 mutants is due to second-site or polar effects. Furthermore, our data support a recent study in which a SPI-1 sipB : : kan R mutant was found to be significantly impaired in its ability to colonize the intestines of pigs following oral inoculation and to invade porcine intestinal mucosa in ligated ileal loops (Boyen et al., 2006b ).
An attenuated mutant with a transposon insertion in safA was identified in our screen. The safABCD operon is located within Salmonella enterica centisome 7 genomic island (SCI), also known as SPI-6 in Salmonella Typhi (Folkesson et al., 2002; Parkhill et al., 2001 ) and encodes Salmonella-specific putative atypical fimbriae. Although the safA mutant was attenuated in our pig model it was not attenuated in a similar STM study in calves and chickens and the S. Typhimurium saf operon was not required for virulence in mice (Folkesson et al., 1999; Morgan et al., 2004) . This may reflect the ability of bacteria to express different adhesins to exploit different animal hosts. To our knowledge this is the first evidence for a role in vivo for this island.
To further validate the STM screen and confirm the role of SafA, two pigs were orally inoculated with a mixed inoculum of the wild-type and a P22 transductant harbouring a safA : : mini-Tn5Km2 mutation that was found to be attenuating in one of two pigs in the primary screen. The ratio of safA mutant to wild-type strain recovered from ileal mucosa 5 days post-infection [0.84±0.014 (mutant log 10 c.f.u. g 21 /wild-type log 10 c.f.u. g 21 ±SEM)] was significantly different to the ratio of safA mutant to wild-type strain in the initial inoculum (0.92±0; P,0.001); however, no statistically significant differences in the magnitude or duration of faecal excretion of the mutant strain relative to the parent were detected (data not shown). The consistent attenuation caused by the safA mutation detected at the site of recovery of STM output pools suggests a subtle role for Saf fimbriae in intestinal colonization and confirms that the screen sensitively detects meaningful phenotypes.
Of the other fimbrial mutants present within the mutant bank only stbC and stbD mutants were attenuated. Despite evidence that type I fimbriae play a role in the colonization of pigs (Althouse et al., 2003) , a fimZ mutant was not attenuated in our screen. However, it is likely that differences in strain, mutation, inoculation dose, mode of delivery and sampling points between the studies account for the disparity in results. Mutation of fimZ reduces expression of type I fimbriae, but simultaneously increases flagella-mediated motility (Clegg & Hughes, 2002) , and we consider that it would be unsafe to directly compare our findings to the role established for the type I fimbriae major subunit (FimA) described previously (Althouse et al., 2003) .
Three of the mutants attenuated in the STM screen had transposon insertions in Salmonella pathogenicity island 3 (SPI-3) genes: sugR, misL and mgtC. SPI-3 is thought to have evolved by a multi-step evolutionary process and its phylogenetic distribution within S. enterica is not uniform. Not surprisingly therefore SPI-3 has a mosaic organization 
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and encodes a group of functionally unrelated proteins (Amavisit et al., 2003; Blanc-Potard et al., 1999) . sugR lies within the phylogenetically variable region of SPI-3 and encodes a putative ATP-binding protein (Blanc-Potard et al., 1999) . Very little is known about sugR and this is the first evidence of a role in vivo for this gene. misL encodes an autotransporter protein, similar to the AIDA-I adhesin of enteropathogenic E. coli, which plays a role in the intestinal colonization of chickens and mice (Blanc-Potard et al., 1999; Dorsey et al., 2005; Morgan et al., 2004) . The exact function of MisL in vivo is unclear; however, recently Dorsey et al. (2005) identified fibronectin as a host ligand for MisL, suggesting that MisL may be involved in bacterial attachment during colonization. The mgtC gene encodes an integral membrane protein of unknown function that is required for systemic virulence in mice (Blanc-Potard & Groisman, 1997) . mgtC forms part of an operon with mgtB, which encodes a P-type ATPase that mediates the influx of Mg 2+ (Snavely et al., 1991) . It has been suggested that, due to its genetic association with mgtB, MgtC might function as a Mg 2+ transporter but it has since been shown that MgtC is neither required for, nor influences, MgtB transport activity (Blanc-Potard & Groisman, 1997; Moncrief & Maguire, 1998) . Recent studies suggest that serovar Typhimurium MgtC may be involved in regulating host or bacterial cell membrane potential and therefore may play a role in influencing cellular ion homeostasis during infection (Gunzel et al., 2006) . The attenuation of the mgtC mutant in our screen is the first in vivo role assigned to this gene using an intestinal colonization model.
A further three mutants with insertions in SPI-3 genes (rmbA, slsA and STM3784) were known to be present in the mutant bank used in this study, but these mutants did not appear to be attenuated in pigs. This result mirrors those obtained with previous screens in calves and chickens in that different SPI-3-encoded genes do not consistently play a role in colonization or host-specificity (Morgan et al., 2004) .
In previous studies SPI-4 was found to be required for colonization of calf ileum but not caecal colonization of chickens (Morgan et al., 2004) . The present study suggests that SPI-4 does not play an important role in intestinal colonization in pigs as only 1 of the 11 SPI-4 insertion mutants in the library was attenuated. A total of eight mutants with defects in siiE (which encodes a secreted y600 kDa protein; Morgan et al., 2007) were screened, of which seven colonized well and one was attenuated. As the SPI-4 mutants tested were present in different pools it is possible that variations in competition dynamics between mutants in a given pool may have dictated why only one of the siiE mutants was lost during colonization of pigs. Taken together, the data support the notion that SPI-4 is specifically required for colonization of bovine intestines (Morgan et al., 2004) .
One of the mutants attenuated in this screen had a transposon insertion in the pipC gene (also known as sigE). pipC is one of six genes found on SPI-5, a 7.6 kb island known to play a role in enteropathogenesis of Salmonella (Wood et al., 1998) . pipC was originally identified in an Virulence and control of Salmonella in pigs in vitro screen for invasion genes and encodes a chaperone specifically required for the stability and/or secretion of SPI-1 effector protein SopB (also known as SigD) also encoded on SPI-5 (Darwin et al., 2001; Galyov et al., 1997; Hong & Miller, 1998) . SopB is an inositol phosphate phosphatase and modulates cell signalling to induce enteritis in concert with other effectors (Galyov et al., 1997; Norris et al., 1998) . Interestingly the pipC mutant was not previously attenuated for colonization in calves (Morgan et al., 2004 ). An additional mutant with an insertion in the SPI-5 pipB gene was also present in the mutant bank used in this study. PipB is an effector protein secreted by T3SS-2, required for colonization of chickens but not calves (Morgan et al., 2004) . In the pig model this mutant was not attenuated, suggesting that this effector may not play a role in the colonization of swine.
The role of LPS in virulence has been well documented in STM-based studies of Gram-negative pathogens in foodproducing animals (Dziva et al., 2004; Morgan et al., 2004; van Diemen et al., 2005) . As expected, several S. Typhimurium mutants predicted to be impaired in LPS biosynthesis were found to be attenuated in pigs. The precise role of LPS in colonization is difficult to determine as in addition to its predicted role in providing protection against host defence mechanisms LPS also plays an important role in ensuring the correct insertion, folding and stability of membrane proteins and other surfaceanchored molecules involved in colonization (Raetz & Whitfield, 2002) .
Three of the attenuated mutants (pagO, pagK and STM1864) identified in our screen had insertions in genes located within a putative phage remnant known to contain the T3SS-1 effector gene sopE2 (McClelland et al., 2001) . pagO and pagK were originally identified as PhoP-PhoQactivated genes by TnphoA mutagenesis; however, little is known about their role during infection (Belden & Miller, 1994) . The Salmonella PhoP-PhoQ system is a twocomponent regulatory system known to regulate, positively and negatively, a number of genes involved in virulence, growth at low Mg 2+ concentrations, and resistance to antimicrobial peptides, bile salts and acid pH (Garcia Vescovi et al., 1996; Groisman, 2001; van Velkinburgh & Gunn, 1999) . The pagO gene encodes a predicted membrane protein which shows homology to PagO from Klebsiella pneumoniae and a product of the Yersinia virulence plasmid and is a member of the drug/metabolite exporter (DME) superfamily (Jack et al., 2001) . In contrast, pagK shows no homology to any publicly available database sequences. STM1864, which is also regulated by PhoPPhoQ, encodes a predicted membrane protein containing a conserved domain common to proteins involved in processes requiring disulphide bond formation (Monsieurs et al., 2005) . Such proteins are often involved in processes such as post-translational modification, protein turnover and protein stability. Interestingly this mutant was also attenuated in a calf colonization model (Morgan et al., 2004) .
Other PhoP-PhoQ-regulated genes were identified in this screen, including the SPI-3 mgtC gene, pcgL, sseK1 which encodes a T3SS-2 secreted effector protein, pSLT026 and a number of SPI-2 encoded genes (Bijlsma & Groisman, 2005; Monsieurs et al., 2005) . The identification of PhoPPhoQ-regulated genes in our model raises the possibility that this system may be required for colonization of pigs by Salmonella.
Assessment of secreted proteins as subunit vaccine candidates
Based on the finding that numerous secreted and surfaceanchored molecules contribute to intestinal colonization of pigs by S. Typhimurium and the fact that vaccines based on extracellular and type III secreted proteins have shown promise against other pathogens, including Y. pestis (Leary et al., 1995) and E. coli O157 : H7 (Potter et al., 2004) , we sought to determine if vaccines based on secreted components of S. Typhimurium are protective in pigs. In order to evaluate the protective effect of these proteins in reducing faecal shedding of S. Typhimurium we vaccinated pigs with secreted protein vaccines from wild-type ST4/74 Nal R or a mock vaccine as described in Methods. To evaluate the role of T3SS-1-secreted proteins in protection a further cohort of pigs was vaccinated in parallel with secreted proteins prepared from a prgH : : mini-Tn5Km2 T3SS-1 mutant under identical conditions and normalized for protein content to FliC and SiiE (Fig. 1) . PrgH is an inner-membrane protein which forms part of the T3SS-1 needle complex required for injection of effector proteins into host cells (Kubori et al., 2000) . The prgH mutant used for vaccine preparation was shown to be attenuated in our pig model of infection (Table 1 ).
All pigs were challenged orally with wild-type ST4/74 Nal R following vaccination. Post-challenge, all animals displayed clinical signs of salmonellosis and shed ST4/74 Nal R from 24 h post-infection (Fig. 2) . Clinical signs of infection, primarily general demeanour, were more pronounced in the mock-vaccinated group with two of the pigs from this group reaching their humane end point at day 39 (2 days post-infection). Faecal shedding in all groups peaked 2 days post-infection (day 39) and although pigs from both the wild-type-vaccine and prgH-vaccine groups shed lower numbers of ST4/74 Nal R when compared with the mockvaccinated animals at this time point (P50.0325 and P50.0615 respectively) only the reduction displayed by wild-type-vaccinated pigs was statistically significant. Wildtype-vaccinated and prgH-vaccinated pigs also shed lower numbers of ST4/74 Nal R when compared with mock-vaccinated pigs on days 1, 3, 4 and 6 post-challenge; however, no statistically significant differences were observed (Fig. 2) .
At post mortem examination ST4/74 Nal R was recovered from selected ileal, caecal and colonic sites (Fig. 3) . There was no significant difference in the number of bacteria recovered from mucosal tissues and lymph nodes between all groups; however, animals vaccinated with the wild-type vaccine and prgH vaccine had lower numbers of ST4/74 Nal R in ileal, caecal and colonic contents when compared with the mock-vaccinated animals (Fig. 3) . The difference in ST4/74 Nal R recovered from ileal and colonic contents from wild-type vaccinated animals when compared with mock-vaccinated animals was statistically significant (P,0.05; Fig. 3 ).
Although the present study indicated that our secreted protein vaccines did not confer long-term protection we were able to demonstrate a significant reduction in faecal shedding during the acute phase of infection and a lessening of disease severity. As the prgH vaccine also reduced shedding during this phase of infection [albeit that this was not significant at the 95 % confidence interval (P50.0615)], it is likely that factors unrelated to T3SS-1 secreted proteins contributed to this effect.
Serum IgG response
Serum IgG responses induced by secreted protein vaccines were analysed by ELISA and are summarized in Fig. 4 . Vaccination by the intramuscular route resulted in the induction of primary and secondary serum antibody responses to proteins secreted by both ST4/74 Nal R and the prgH mutant. Using the wild-type secreted protein vaccine as antigen, serum from pigs vaccinated with wildtype vaccine or prgH vaccine showed significantly higher reactivity than serum from mock-vaccinated pigs (P,0.01; Fig. 4a) . Similarly using the prgH vaccine as antigen produced comparable levels of reactivity against serum from both wild-type and prgH vaccinated pigs (Fig. 4b) . Serum from mock-vaccinated pigs showed minimal reactivity with both wild-type and prgH mutant secreted protein vaccines (Fig. 4) .
To define further the serum IgG responses, wild-type and prgH mutant vaccine preparations were separated by 10 % SDS-PAGE, transferred to nitrocellulose and probed with sera taken from vaccinated animals over the course of this study (Fig. 5) . Vaccination with wild-type vaccine resulted in the induction of antibody response to known T3SS-1 secreted proteins (Fig. 5b) ; however, such responses were absent in pigs vaccinated with prgH mutant and mock vaccine (Fig. 5a, c) .
Vaccines based on secreted components of other Gramnegative pathogens have shown promise. For example, vaccination of calves using secreted proteins from E. coli O157 : H7 generated responses against type III secreted proteins and was protective against experimental challenge (Potter et al., 2004) and in the field (A. Potter, personal communication) . Further studies to dissect the basis of protection and optimize the vaccine dose, adjuvant and route of delivery of the vaccine used in this study are therefore warranted. It is also possible that additional factors combined with this vaccine preparation may be required to improve levels of protection, as suggested by the multi-factorial nature of colonization in pigs highlighted by the STM screen.
In conclusion, this study has provided a better understanding of the host-specific requirements for establishment of S. Typhimurium infection in a key reservoir host and identified numerous genes with previously unrecognized roles in colonization. Inert vaccines that exploit the pivotal role of secreted components conferred limited protection against intestinal colonization and the basis of the protective effect remains to be elucidated. . Immunoblot analysis of sera from pigs vaccinated with ST4/74 Nal R secreted protein preparation, prgH mutant secreted protein preparation or mock vaccine. Each blot contains kaleidoscope pre-stained standards (Bio-Rad; lane 1), secreted proteins from wild-type ST4/74 Nal R (lane 2) and secreted proteins from ST4/74 Nal R prgH : : mini-Tn5Km2 (lane 3). Proteins were separated by SDS-10 % PAGE, transferred to nitrocellulose and probed with representative sera from one animal from each group taken on days 0, 22 and 37 of the study (pre-vaccination, preboost and pre-challenge respectively). (a) Mock-vaccinated group, (b) wild-type vaccinated group, (c) prgH-mutant vaccinated group.
